Expression of matrix metalloproteinase (MMP)-2, MMP-14 and tissue inhibitor of matrix metalloproteinase (TIMP)-2 during bovine placentation and at term with or without placental retention

Theriogenology

Volumn 75, Issue 6, 2011, Pages 1104-1114

  Dilly, M ^a   Hambruch, N ^a   Shenavai, S ^b   Schuler, G ^b   Froehlich, R ^a   Haeger, J D ^a   Ozalp, G R ^c   Pfarrer, C ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c ULUDAG UNIVERSITY   (Turkey)

Author keywords

Bovine placenta; Matrix metalloproteinases

Indexed keywords

GELATINASE A; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL; ANIMAL DISEASE; ARTICLE; CATTLE; CATTLE DISEASE; EMBRYO MEMBRANE; ENZYMOLOGY; FEMALE; METABOLISM; PHYSIOLOGY; PLACENTA; PREGNANCY; REPRODUCTION; RETAINED PLACENTA; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CATTLE; CATTLE DISEASES; EXTRAEMBRYONIC MEMBRANES; FEMALE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; PLACENTA; PLACENTA, RETAINED; PLACENTATION; PREGNANCY; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

ANIMALIA; BOS; BOVINAE;

EID: 79952042979     PISSN: 0093691X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.theriogenology.2010.11.019     Document Type: Article

References (66)

1. Leiser R., Kaufmann P. Placental structure: in a comparative aspect. Exp Clin Endocrinol 1994, 102:122-134.
2. Wooding F.B., Wathes D.C. Binucleate cell migration in the bovine placentome. J Reprod Fertil 1980, 59:425-430.
3. Klisch K., Hecht W., Pfarrer C., Schuler G., Hoffmann B., Leiser R. DNA content and ploidy level of bovine placentomal trophoblast giant cells. Placenta 1999, 20:451-458.
4. Leiser R., Pfarrer C., Abd-Elnaeim M., Dantzer V. Feto-maternal anchoring in epitheliochorial and endotheliochorial placental types studied by histology and microvascular corrosion casts. Troph Res 1998, 12:21-39.
5. Paisley L.G., Mickelsen W.D., Anderson P.B. Mechanisms and therapy for retained fetal membranes and uterine infections of cows: A review. Theriogenology 1986, 25:353-381.
6. Gross T.S., Williams W.F., Russek-Cohen E. Cellular changes in the peripartum bovine fetal placenta related to placental separation. Placenta 1991, 12:27-35.
7. Williams W.F., Margolis M.J., Manspeaker J., Douglass L.W., Davidson J.P. Peripartum changes in the bovine placenta related to fetal membrane retention. Theriogenology 1987, 28:213-223.
8. Al-Sadi H.I., Majeed A.F., Ridha A.M. Histopathology of retained bovine fetal membranes. Theriogenology 1994, 42:273-278.
9. Shenavai S., Hoffmann B., Dilly M., Pfarrer C., Ozalp G.R., Caliskan C., Seyrek-Intas K., Schuler G. Use of the progesterone receptor antagonist aglepristone to characterize the role of progesterone withdrawal for parturition and placental release in cows. Reproduction 2010, 140:623-632.
10. Fourichon C., Seegers H., Malher X. Effect of disease on reproduction in the dairy cow: a meta-analysis. Theriogenology 2000, 53:1729-1759.
11. Kelton D.F., Lissemore K.D., Martin R.E. Recommendations for recording and calculating the incidence of selected clinical diseases of dairy cattle. J Dairy Sci 1998, 81:2502-2509.
12. Laven R.A., Peters A.R. Bovine retained placenta: aetiology, pathogenesis and economic loss. Vet Rec 1996, 139:465-471.
13. Peters A.R., Laven R.A. Treatment of bovine retained placenta and its effects. Vet Rec 1996, 139:535-539.
14. Joosten I., Stelwagen J., Dijkhuizen A.A. Economic and reproductive consequences of retained placenta in dairy cattle. Vet Rec 1988, 123:53-57.
15. Echternkamp S.E., Gregory K.E. Effects of twinning on gestation length, retained placenta, and dystocia. J Anim Sci 1999, 77:39-47.
16. Patterson D.J., Bellows R.A., Burfening P.J. Effects of caesarean section, retained placenta and vaginal or uterine prolapse on subsequent fertility in beef cattle. J Anim Sci 1981, 53:916-921.
17. Muller L.D., Owens M.J. Factors associated with the incidence of retained placentas. J Dairy Sci 1974, 57:725-728.
18. Kankofer M., Wiercinski J., Zerbe H. Prostaglandin E(2) 9-keto reductase activity in bovine retained and not retained placenta. Prostaglandins Leukot Essent Fatty Acids 2002, 66:413-417.
19. Takagi M., Fujimoto S., Ohtani M., Miyamoto A., Wijagunawardane M.P., Acosta T.J., Miyazawa K., Sato K. Bovine retained placenta: hormonal concentrations in fetal and maternal placenta. Placenta 2002, 23:429-437.
20. Grunert E., Ahlers D., Heuwieser W. The role of endogenous estrogens in the maturation process of the bovine placenta. Theriogenology 1989, 31:1081-1091.
21. Wischral A., Nishiyama-Naruke A., Curi R., Barnabe R.C. Plasma concentrations of estradiol 17beta and PGF2alpha metabolite and placental fatty acid composition and antioxidant enzyme activity in cows with and without retained fetal membranes. Prostagland Lipid Mediat 2001, 65:117-124.
22. Wischral A., Verreschi I.T., Lima S.B., Hayashi L.F., Barnabe R.C. Pre-parturition profile of steroids and prostaglandin in cows with or without foetal membrane retention. Anim Reprod Sci 2001, 67:181-188.
23. Beagley J.C., Whitman K.J., Baptiste K.E., Scherzer J. Physiology and treatment of retained fetal membranes in cattle. J Vet Intern Med 2010, 24:261-268.
24. McNaughton A.P., Murray R.D. Structure and function of the bovine fetomaternal unit in relation to the causes of retained fetal membranes. Vet Rec 2009, 165:615-622.
25. Eiler H., Hopkins F.M. Bovine retained placenta: effects of collagenase and hyaluronidase on detachment of placenta. Biol Reprod 1992, 46:580-585.
26. Fecteau K.A., Haffner J.C., Eiler H. The potential of collagenase as a new therapy for separation of human retained placenta: hydrolytic potency on human, equine and bovine placentae. Placenta 1998, 19:379-383.
27. Beceriklisoy H.B., Walter I., Schafer-Somi S., Miller I., Kanca H., Izgur H., Aslan S. Matrix metalloproteinase (MMP)-2 and MMP-9 activity in the canine uterus before and during placentation. Reprod Domest Anim 2007, 42:654-659.
28. Hashizume K. Analysis of uteroplacental-specific molecules and their functions during implantation and placentation in the bovine. J Reprod Dev 2007, 53:1-11.
29. Cohen M., Meisser A., Bischof P. Metalloproteinases and human placental invasiveness. Placenta 2006, 27:783-793.
30. Maj J.G., Kankofer M. Activity of 72-kDa and 92-kDa matrix metalloproteinases in placental tissues of cows with and without retained fetal membranes. Placenta 1997, 18:683-687.
31. Riley S.C., Webb C.J., Leask R., McCaig F.M., Howe D.C. Involvement of matrix metalloproteinases 2 and 9, tissue inhibitor of metalloproteinases and apoptosis in tissue remodelling in the sheep placenta. J Reprod Fertil 2000, 118:19-27.
32. Uekita T., Yamanouchi K., Sato H., Tojo H., Seiki M., Tachi C. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus). Placenta 2004, 25:810-819.
33. Vagnoni K.E., Zheng J., Magness R.R. Matrix metalloproteinases-2 and -9, and tissue inhibitor of metalloproteinases-1 of the sheep placenta during the last third of gestation. Placenta 1998, 19:447-455.
34. Kizaki K., Ushizawa K., Takahashi T., Yamada O., Todoroki J., Sato T., Ito A., Hashizume K. Gelatinase (MMP-2 and -9) expression profiles during gestation in the bovine endometrium. Reprod Biol Endocrinol 2008, 6:66.
35. Walter I., Boos A. Matrix metalloproteinases (MMP-2 and MMP-9) and tissue inhibitor-2 of matrix metalloproteinases (TIMP-2) in the placenta and interplacental uterine wall in normal cows and in cattle with retention of fetal membranes. Placenta 2001, 22:473-483.
36. Wang Z., Juttermann R., Soloway P.D. TIMP-2 is required for efficient activation of proMMP-2 in vivo. J Biol Chem 2000, 275:26411-26415.
37. Brew K., Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta 2010, 1803:55-71.
38. Pfarrer C.D. Characterization of the bovine placenta by cytoskeleton, integrin receptors, and extracellular matrix. Methods Mol Med 2006, 121:323-335.
39. Pfarrer C., Weise S., Berisha B., Schams D., Leiser R., Hoffmann B., Schuler G. Fibroblast growth factor (FGF)-1, FGF2, FGF7 and FGF receptors are uniformly expressed in trophoblast giant cells during restricted trophoblast invasion in cows. Placenta 2006, 27:758-770.
40. Schnorr B. Altersbestimmung der Frucht - Ein Kurzlehrbuch. Embryologie der Haustiere 1996, 64-65. Ferdinand Enke Verlag, Stuttgart. B. Schnorr (Ed.).
41. Rabot A., Sinowatz F., Berisha B., Meyer H.H., Schams D. Expression and localization of extracellular matrix-degrading proteinases and their inhibitors in the bovine mammary gland during development, function, and involution. J Dairy Sci 2007, 90:740-748.
42. Bionaz M., Loor J.J. Identification of reference genes for quantitative real-time PCR in the bovine mammary gland during the lactation cycle. Physiol Genomics 2007, 29:312-319.
43. Claydon R.K. Induction of parturition in cattle during the later stages of pregnancy: a comparison of three treatments. Vet Rec 1984, 114:113-114.
44. Johnson C.T., Jackson P.S. Induction of parturition in cattle with cloprostenol. Br Vet J 1982, 138:212-224.
45. Rasmussen F.E., Wiltbank M.C., Christensen J.O., Grummer R.R. Effects of fenprostalene and estradiol-17 beta benzoate on parturition and retained placenta in dairy cows and heifers. J Dairy Sci 1996, 79:227-234.
46. Boos A., Janssen V., Mulling C. Proliferation and apoptosis in bovine placentomes during pregnancy and around induced and spontaneous parturition as well as in cows retaining the fetal membranes. Reproduction 2003, 126:469-480.
47. Konigsson K., Gustafsson H., Kindahl H. 15-Ketodihydro-PGF(2 alpha), progesterone and uterine involution in primiparous cows with induced retained placenta and post-partal endometritis treated with oxytetracycline and flunixin. Reprod Domest Anim 2002, 37:43-51.
48. Takagi M., Yamamoto D., Ohtani M., Miyamoto A. Quantitative analysis of messenger RNA expression of matrix metalloproteinases (MMP-2 and MMP-9), tissue inhibitor-2 of matrix metalloproteinases (TIMP-2), and steroidogenic enzymes in bovine placentomes during gestation and postpartum. Mol Reprod Dev 2007, 74:801-807.
49. Rawdanowicz T.J., Hampton A.L., Nagase H., Woolley D.E., Salamonsen L.A. Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha. J Clin Endocrinol Metab 1994, 79:530-536.
50. Pfarrer C., Hirsch P., Guillomot M., Leiser R. Interaction of integrin receptors with extracellular matrix is involved in trophoblast giant cell migration in bovine placentomes. Placenta 2003, 24:588-597.
51. Boos A., Stelljes A. Immunohistochemical Detection of Collagen Types I, III and IV in the Bovine. Reprod Domest Anim 2000, 35:174-175.
52. Boos A., Stelljes A., Kohtes J. Collagen types I, III and IV in the placentome and interplacentomal maternal and fetal tissues in normal cows and in cattle with retention of fetal membranes. Cells Tissues Organs 2003, 174:170-183.
53. Bischof P., Meisser A., Campana A. Paracrine and autocrine regulators of trophoblast invasion--a review. Placenta 2000, 21(Suppl A):S55-S60.
54. Curry T.E., Osteen K.G. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev 2003, 24:428-465.
55. Bai S.X., Wang Y.L., Qin L., Xiao Z.J., Herva R., Piao Y.S. Dynamic expression of matrix metalloproteinases (MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy. Reproduction 2005, 129:103-113.
56. Bjorn S.F., Hastrup N., Lund L.R., Dano K., Larsen J.F., Pyke C. Co-ordinated expression of MMP-2 and its putative activator, MT1-MMP, in human placentation. Mol Hum Reprod 1997, 3:713-723.
57. Wang H., Li Q., Shao L., Zhu C. Expression of matrix metalloproteinase-2, -9, -14, and tissue inhibitors of metalloproteinase-1, -2, -3 in the endometrium and placenta of rhesus monkey (Macaca mulatta) during early pregnancy. Biol Reprod 2001, 65:31-40.
58. Schultz R.M., Silberman S., Persky B., Bajkowski A.S., Carmichael D.F. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res 1988, 48:5539-5545.
59. Zucker S., Drews M., Conner C., Foda H.D., DeClerck Y.A., Langley K.E., Bahou W.F., Docherty A.J., Cao J. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J Biol Chem 1998, 273:1216-1222.
60. Boos A., Kohtes J., Stelljes A., Zerbe H., Thole H.H. Immunohistochemical assessment of progesterone, oestrogen and glucocorticoid receptors in bovine placentomes during pregnancy, induced parturition, and after birth with or without retention of fetal membranes. J Reprod Fertil 2000, 120:351-360.
61. Schuler G., Greven H., Kowalewski M.P., Doring B., Ozalp G.R., Hoffmann B. Placental steroids in cattle: hormones, placental growth factors or by-products of trophoblast giant cell differentiation?. Exp Clin Endocrinol Diabetes 2008, 116:429-436.
62. Schuler G., Teichmann U., Taubert A., Failing K., Hoffmann B. Estrogen receptor beta (ERbeta) is expressed differently from ERalpha in bovine placentomes. Exp Clin Endocrinol Diabetes 2005, 113:107-114.
63. Schuler G., Wirth C., Klisch K., Pfarrer C., Leiser R., Hoffmann B. Immunolocalization of progesterone receptors in bovine placentomes throughout mid and late gestation and at parturition. Biol Reprod 1999, 61:797-801.
64. Boos A., Kohtes J., Janssen V., Mulling C., Stelljes A., Zerbe H., Hassig M., Thole H.H. Pregnancy effects on distribution of progesterone receptors, oestrogen receptor alpha, glucocorticoid receptors, Ki-67 antigen and apoptosis in the bovine interplacentomal uterine wall and foetal membranes. Anim Reprod Sci 2006, 91:55-76.
65. Damsky C.H., Librach C., Lim K.H., Fitzgerald M.L., McMaster M.T., Janatpour M., Zhou Y., Logan S.K., Fisher S.J. Integrin switching regulates normal trophoblast invasion. Devel 1994, 120:3657-3666.
66. Sutherland A.E., Calarco P.G., Damsky C.H. Developmental regulation of integrin expression at the time of implantation in the mouse embryo. Devel 1993, 119:1175-1186.